Isolation and characterization of a cDNA clone showing C-myc binding-activity

Area of Science:

• Molecular Biology
• Oncology
• Gene Regulation

Background:

• The human c-myc oncogene is crucial in cell proliferation and is frequently dysregulated in cancer.
• Understanding the regulation of c-myc transcription is vital for cancer research and therapeutic development.

Purpose of the Study:

• To identify and characterize novel proteins that bind to the regulatory regions of the human c-myc oncogene.
• To investigate the role of a newly discovered c-myc promoter binding protein (MBP-2) in regulating c-myc transcription.

Main Methods:

• Isolation of a cDNA clone encoding MBP-2 from a HeLa cell expression library.
• DNA binding assays to determine the specific sequence recognized by MBP-2.
• Northern blot and Western blot analyses to assess MBP-2 expression and protein size in various cell lines and tissues.
• Nucleotide sequence analysis of the MBP-2 cDNA.

Main Results:

• A novel c-myc promoter binding protein (MBP-2) was identified.
• MBP-2 specifically binds to a critical regulatory sequence (-46 to -64) of the human c-myc P2 promoter.
• A single base substitution in the target sequence abolished MBP-2 binding.
• MBP-2 cDNA detected a 1.7 kb transcript in human tissues, and Western blot showed an ~80 kDa protein in HeLa and NIH3T3 cells.
• Sequence analysis indicated MBP-2 is a unique DNA-binding protein.

Conclusions:

• MBP-2 is a novel DNA-binding protein that interacts with a key regulatory element of the human c-myc oncogene.
• MBP-2 likely plays a significant role in the transcriptional regulation of the c-myc gene.
• Further research into MBP-2 could offer insights into c-myc-driven cancers.